DIH Holdings US, Inc · OTC:DHAI
DIH Holdings US — DIH Holding US — Investor Presentation (August 2024)
27 slides from DIH Holdings US's investor presentation, Aug 19, 2024
Slide 1: DIH Investor Presentation August 2024
DIH Dedicated to restoring mobility and Enhancing human performance Investor Presentation August 2024 Nasdaq: DHAI
Slide 2: Disclaimer and forward-looking statements
In this presentation, “DIH”, the “Company”, “we”, “us” and “our” mean DIH Holding US, Inc, a Delaware corporation (Nasdaq: DHAI). All amounts are in U.S. dollars unless otherwise indicated. The information contained herein does not purport to contain all of the information about the Company. The inf
Slide 3: DIH at a glance: Robotic-enabled movement platform
DIH at a glance: Robotic-enabled movement platform improving the lives of people with disabilities and functional impairments
Slide 4: Total solution provider in neuro-rehabilitation and human performance research
Investor presentation total solution provider in neuro-rehabilitation and human performance research Improving lives by providing human movement therapy while empowering leading scientists and clinics to study balance and movement disorders through Advanced Technology. Page 4
Slide 5: Addressing increased market demand with innovative solutions
Investor presentation addressing increased market demand by providing innovative solutions for hospitals, clinics, and research Institutions DIH – a Global Solution Provider, has the broadest portfolio in neuro-rehabilitation and human performance research, with over 4,500 devices installed. With an
Slide 6: DIH at a glance
Investor presentation dih at a glance Page 6 Products & Systems 19 $64.5M FY242 Revenue 19% YoY increase USA, Singapore, Chile, Slovenia, Germany 5 Commercial Regions Employees 243 in 9 global locations from 33 nationalities ` Devices installed1 4,500+ 1,500+ Medical device registrations in 75 count
Slide 7: Meeting market demands with innovative Advanced Technologies
Meeting market demands with innovative Advanced Technologies
Slide 8: Market opportunity: end-to-end broad market coverage
Patients Neurological Stroke SCI & cerebral palsy Parkinson’s disease Traumatic brain injury Orthopedic Amputation Osteoarthritis Musculoskeletal disorders Geriatric & Pediatric Aging population with an increased risk of falling and functional impairment Pediatric patients with mobility impairments
Slide 9: Integrated solutions for the entire continuum of care
Investor presentation integrated solutions for the entire continuum of care across multiple markets Rehabilitation Hospitals and Outpatient Clinics (“Hospital and Clinic Market”) Research & Human Movement Labs* (“Research Market”) ARM & HAND GAIT & BALANCE DATA INTEGRATION C-MILL ANDAGO RYSEN LOKOMA
Slide 10: Global trends and market drivers
Investor presentation global trEnds and MARKET DRIVERS Page 10 Aging population Advanced Technology is key to meeting market demands. Increasing neurological disorders and related disabilities Need of care and lack of therapist 1 WHO: Ageing and Health; https://www.who.int/news-room/fact-sheets/deta
Slide 11: Continuum of care for upper extremities rehabilitation
Investor presentation CONTINUUM OF CARE FOR Upper extremities REHABILITATION ARMEO®SENSO ARMEO®SPRING PRO & ARMEO®SPRING ARMEO®POWER ROBOTIC ARM MOVEMENT SUPPORT TRAINING PATIENT NEEDS PATIENT ABILITY (MMT) MMT 0 MMT 1 MMT 2 MMT 3 MMT 4 MMT 5 ARM WEIGHT SUPPORT TRAINING SELF-DIRECTED TRAINING MMT: M
Slide 12: Continuum of care for lower extremities rehabilitation
PATIENT ABILITY (FAC) Investor presentation continuum of CARE FOR LOWER EXTREMITIES REHABILITATION C-MIll Andago® rysenTM LOKOMAT® ERIGO® FAC 0 FAC 1 FAC 2 FAC 3 FAC 4 FAC 5 SAFEGAIT* MOBILIZATION AND VERTICALIZATION REPETITIVE, PHYSIOLOGICAL GAIT TRAINING OVERGROUND GAIT AND BALANCE TRAINING GAIT A
Slide 13: Research portfolio
Investor presentation research PORTFOLIO Page 13 Caren extended* GRAIL* M-GAIT* Modular Gait Lab Caren high end* Targets all aspects of balance and locomotion. The use of virtual reality enables researchers to assess the subject’s behavior and includes sensory inputs like visual, auditory and vestib
Slide 14: A trusted partner every step of the way
Investor presentation A trusted partner every step of the way We provide guidelines and support customers in building their rehabilitation project. We find the right solution to match the organizations’ needs, space and budget. BUSINESS MODEL and PLANNING To help make the best use of our solutions,
Slide 15: Trusted by leading rehabilitation and research institutions
Investor presentation trusted by leading rehabilitation and research institutions >60 Leading Institutions trust DIH DIH collaborates with world renowned institutions in rehabilitation and research as reference centers and innovation partners Page 15
Slide 16: Market leading product investigation by number of publications
C-Mill 70* GRAIL & M-Gait 234* Investor presentation Market leading product investigation as evidenced by ToTAL number of publications1 Page 16 1The Knowledge Platform includes all research articles, conference proceedings, and theses available on our devices and can be accessed via knowledge.hocoma
Slide 17: Competitive landscape
Early Entrants Emerging Players Industry Leader DIH is uniquely positioned as a leader in rehabilitation-tech and research markets Investor presentation Competitive Landscape Page 17 LFWD (NASDAQ) EKSO (NASDAQ) DVL (ASX) DHAI (NASDAQ)
Slide 18: Sources of Competitive Advantage
Investor presentation Sources of Competitive Advantage Page 18 Leading Technology Highly recognized premier brands and technologies in our industry, endorsed by leading rehabilitation institutes and opinion leaders Product Portfolio Broadest product portfolio in advanced robotics and sophisticated V
Slide 19: Investment highlights
Page 19 Global solution provider combining innovative robotic and VR technologies with clinical integration and proprietary insights. Transformative total solutions provider and consolidator in a fragmented and manual-labor-driven industry. Innovative and broad product portfolio, covering the entire
Slide 20: Way Forward - Investment Opportunity
Way Forward - Investment Opportunity
Slide 21: Transforming the rehabilitation care model
High manual therapies costs are primed for disruption across care centers Robotic solutions provide value and save costs, creating flexibility within institutional budgets Investor presentation Transforming the rehabilitation care model Page 21 Rehab Hospitals Long-Term Care & Skilled Nursing Facili
Slide 22: Phase 1 Strategic Growth
Phase 3 Phase 2 Penetrate Markets Drive Market Standardization Develop Total Solutions Expand presence in US and EU Prioritize product innovation and integration efforts Enter new institutions Further penetrate existing accounts Leverage global platforms and infrastructure Realize economies of scale
Slide 23: Financial Highlights
DELIVER INSPIRATION & HEALTH Financial Highlights
Slide 24: Strong revenue growth and market penetration
Page 24 Investor presentation Strong revenue growth and market penetration $64.5M Revenue, +19% YoY growth 79% devices 17% services 4% other ($8.4M) Net Loss 46% Gross Margin $5.2M Cash Flow from Operations Fiscal Year 2024 Fiscal Year 2025 Revenue Guidance: $74.0M-$77.0M 19% YoY Growth 17% YoY Grow
Slide 25: DIH executive officers
Investor presentation DIH executive Officers Page 25 Jason Chen Chief Executive Officer and Chairman of the Board Lynden Bass Chief Financial Officer Dr. Patrick Bruno Chief Market Officer
Slide 26: International management team
Investor presentation International management team Page 26 CEO and Chairman of the Board Jason Chen Chief Financial Officer Lynden Bass Chief Market Officer Hospital & Clinic Patrick Bruno Senior Vice President Sales – EMEA Indirect Slavko Skafar Vice President Global Operations Walther Geiger Vice
Slide 27: Thank you
Thank you For more information contact [email protected]